Citadel Advisors’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Sell |
|
|||||
|
2025
Q1 | $87.6K | Buy |
|
|||||
|
2024
Q4 | $90.2K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $10K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $73K | Buy |
|
|||||
|
2021
Q2 | $62K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $89K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $99K | Buy |
|
|||||
|
2020
Q1 | $27K | Buy |
|
|||||
|
2019
Q4 | $58K | Sell |
|
|||||
|
2019
Q3 | $49K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $50K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $19K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $24K | Sell |
|
|||||
|
2017
Q3 | $43K | Buy |
|
|||||
|
2017
Q2 | $32K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $10K | Sell |
|
|||||
|
2015
Q2 | $20K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $20K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $20K | Sell |
|
|||||
|
2014
Q1 | $106K | Buy |
|